发明名称 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS
摘要 Spoj predstavljen formulom I: ili njegova farmaceutski prihvatljiva sol, naznačen time što: X1 je C E1;X2 je N ili C E1;Q1 je ;gdje su svaki X11, X12 i X13 jednaki C E11; i bilo koji ili dva od X14, X15 i X16 su N i ostali su C E11; R1 je C0-10alkil, cikloC3-10alkil, bicikloC5-10alkil, aril, heteroaril, aralkil, heteroaralkil, heterociklil, heterobicikloC5-10alkil, spiroalkil ili heterospiroalkil, gdje je bilo koji od njih izborno supstituiran jednim ili više nezavisnih G11 supstituenata; Svaki E1, E11, G1 i G41 nezavisno je halo, CF3, OCF3, OR2, NR2R3(R2a)j1, C(=O)R2, CO2R2, CONR2R3,NO2, CN, S(O)j1R2, SO2NR2R3, NR2C(=O)R3, NR2C(=O)OR3, NR2C(=O)NR3R2a, NR2S(O)j1R3, C(=S)OR2, C(=O)SR2, NR2C(=NR3)NR2aR3a, NR2C(=NR3)OR2a,NR2C(=NR3)SR2a, OC(=O)OR2, OC(=O)NR2R3, OC(=O)SR2, SC(=O)OR2, SC(=O)NR2R3, C0-10alkil, C2-10alkenil, C2-10alkinil, C1-10alkoksiC1-10alkil, C1-10alkoksiC2-10alkenil, C1-10alkoksiC2-10alkinil, C1-10alkiltioC1-10alkil, C1-10alkiltioC2-10alkenil, C1-10alkiltioC2-10alkinil, cikloC3-8alkil, cikloC3-8alkenil, cikloC3-8alkilC1-10alkil, cikloC3-8alkenilC1-10alkil, cikloC3-8alkilC2-10alkenil, cikloC3-8alkenilC2-10alkenil, cikloC3-8alkilC2-10alkinil, cikloC3-8alkenilC2-10alkinil, heterociklil C0-10alkil, heterociklil C2-10alkenil ili heterociklil C2-10alkinil, gdje je bilo koji od njih izborno supstituiran jednim ili više nezavisnih halo, okso, CF3, OCF3, OR222, NR222R333(R222a)j1a, C(=O)R222, CO2R222, C(=O)NR222R333, NO2, CN, S(=O)j1aR222, SO2NR222R333, NR222C(=O)R333, NR222C(=O)OR333, NR222C(=O)NR333R222a, NR222S(O)j1aR333, C(=S)OR222, C(=O)SR222, NR222C(=NR333)NR222aR333a, NR222C(=NR333)OR222a, NR222C(=NR333)SR222a, OC(=O)OR222, OC(=O)NR222R333, OC(=O)SR222, SC(=O)OR222 ili SC(=O)NR222R333 supstituenata; ili E1, E11 ili G1 izborno je (W1)n (Y1)m R4; ili E1, E11, G1 ili G41 izborno nezavisno je aril C0-10alkil, aril C2-10alkenil, aril C2-10alkinil, hetaril C0-10alkil, hetaril C2-10alkenil ili hetaril C2-10alkinil, gdje je bilo koji od njih izborno supstituiran jednim ili više nezavisnih halo, CF3, OCF3,OR222, NR222R333(R222a)j2a, C(O)R222, CO2R222, C(=O)NR222R333, NO2, CN, S(O)j2aR222, SO2NR222R333, NR222C(=O)R333, NR222C(=O)OR333, NR222C(=O)NR333R222a, NR222S(O)j2aR333, C(=S)OR222, C(=O)SR222, NR222C(=NR333)NR222aR333a, NR222C(=NR333)OR222a, NR222C(=NR333)SR222a, OC(=O)OR222, OC(=O)NR222R333, OC(=O)SR222, SC(=O)OR222 ili SC(=O)NR222R333 supstituenata; G11 je halo, okso, CF3, OCF3, OR21, NR21R31(R2a1)j4, C(O)R21, CO2R21, C(=O)NR21R31, NO2, CN, S(O)j4R21, SO2NR21R31, NR21(C=O)R31, NR21C(=O)OR31, NR21C(=O)NR31R2a1, NR21S(O)j4R31, C(=S)OR21, C(=O)SR21, NR21C(=NR31)NR2a1R3a1, NR21C(=NR31)OR2a1, NR21C(=NR31)SR2a1, OC(=O)OR21, OC(=O)NR21R31, OC(=O)SR21,SC(=O)OR21, SC(=O)NR21R31, P(O)OR21OR31, C1-10alkiliden, C0-10alkil, C2-10alkenil, C2-10alkinil, C1-10alkoksiC1-10alkil, C1-10alkoksiC2-10alkenil, C1-10alkoksiC2-10alkinil, C1-10alkiltioC1-10alkil, C1-10alk
申请公布号 HRP20090495(T1) 申请公布日期 2009.10.31
申请号 HR2009P000495T 申请日期 2009.09.16
申请人 OSI PHARMACEUTICALS 发明人 LEE D. ARNOLD;CARA CESARIO;HEATHER COATE;ANDREW PHILIP CREW;HANQING DONG;KENNETH FOREMAN;AYAKO HONDA;RADOSLAW LAUFER;AN-HU LI;KRISTEN MICHELLE MULVIHILL;MARK JOSEPH MULVIHILL;ANTHONY NIGRO;BIJOY PANICKER;ARNO G. STEINIG;YINGCHUAN SUN;QINGHUA WENG;DOUGLAS S. WERNER;MICHAEL J. WYLE;TAO ZHANG
分类号 C07D487/04;A61K31/437;A61K31/4985;A61K31/5025;A61K31/519;A61K31/53;A61P11/06;A61P17/06;A61P25/00;A61P35/00;C07D471/04 主分类号 C07D487/04
代理机构 代理人
主权项
地址